
Ryan Chow
@sciencechow
@PennIMResidents, incoming heme/onc fellow @PennCancer | @YaleMed MD/PhD w/ @sidichen | Harvard '16 | ryanchow.org
ID: 1189036811269672960
https://www.ryanchow.org/ 29-10-2019 04:30:48
92 Tweet
332 Followers
516 Following

My favorite study from this past year. What a good way to end our MD PhD time together Yale School of Medicine. We challenge the idea that mutations in IFN pathways are always a protective feature of tumors against immunotherapy. Lots to more to learn and to model for the future.

So grateful and overjoyed that Ryan Chow and I will be continuing our physician-scientist training at Penn Medicine! Thank you so much to all our mentors at Yale School of Medicine Yale MDPhD Program Yale Department of Immunobiology Yale Department of Genetics Yale Dermatology Yale Cancer Center for their support! #Match2023



Excited to see some of my thesis work finally published in PLOS Biology!Wouldnāt have been possible without Craig Wilen Jin Wei Mia Madel Alfajaro Kadoch Lab Ajinkya Patil Scott Biering Patrick Hsu Silvana Konermann Qin Yan, PhD @JohnDoench Ryan Chow Wesley Cai, PhD & more.

Our work at Nature Immunology on a new way of cell therapy engineering. Proud of 1st author Ariel & team. Special Tx to Dr. Levchenko. Yale University Yale Department of Genetics Yale Cancer Center Yale West Campus Yale Center for Biomedical Data Science (CBDS) Yale School of Medicine nature.com/articles/s4159ā¦


That eric hoyeon song could pull this off *WHILE IN RESIDENCY* is absolutely bonkers to me. 10/10 would let him inject AAVs into my eyes any day


Phenotypic Evaluation of Deep Learning Models for Classifying Germline Variant Pathogenicity npj Journals ⢠This study evaluates the real-world utility of three state-of-the-art deep learning modelsāAlphaMissense, EVE, and ESM1bāin classifying germline variants associated with


New npj Journals paper by Ryan Chow co-mentored w/ Katherine Nathanson BasserBRCA on reliability of #deeplearning to predict variant pathogenicity. #AI recapitulate ClinVar classifications for pathogenic variants, but poorly predict pathogenicity for VUS's #breastcancer

